Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Alzheimer's disease (AD) is an age-related neurodegenerative disease beginning with memory loss and eventually leading to the permanent disability to carry on daily activities and to respond to the environment. The pathogenesis of AD is complex, and the cholinergic deficiency hypothesis, which is generally accepted in the world, holds that the absence of acetylcholine in the brains of AD patients is the key cause of the disease. Acetylcholinesterase (AChE) could degrade the neurotransmitter acetylcholine and block its excitatory stimulation on postsynaptic membrane, so AChE is closely related to the pathogenesis of AD. Acetylcholinesterase inhibitor can restore the level of acetylcholine by inhibiting AChE activity and thus alleviating the symptoms of AD patients. This service provides a simple strategy for screening AChE inhibitors from traditional Chinese medicines (TCMs) by capillary electrophoresis (CE) analysis combined with enzymatic assay, in which immobilized AChE is employed.